TY - JOUR KW - Covid-19 AU - Kurizky P AU - Cerqueira S AU - Cunha D AU - de Albuquerque C AU - Aires R AU - da Mota L AU - Gomes CM AB -
Coronavirus disease 2019 (COVID-19) was first officially described in Brazil on February 26th, 2020. The accumulation of reports of concomitant infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathogens that cause diseases endemic to tropical countries, such as dengue and chikungunya fever, has started to draw attention. Chagas disease and leprosy remain public health problems in many developing countries, such as Brazil. In this manuscript, we describe a case of concomitant leprosy, Chagas disease, and COVID-19, highlighting the cutaneous manifestations of SARS-CoV-2 infection and the clinical behavior of household contacts who previously received prophylactic Bacillus Calmette-Guérin vaccines.
BT - Revista da Sociedade Brasileira de Medicina Tropical C1 - https://www.ncbi.nlm.nih.gov/pubmed/33174962 DA - 01/2020 DO - 10.1590/0037-8682-0504-2020 J2 - Rev Soc Bras Med Trop LA - eng N2 -Coronavirus disease 2019 (COVID-19) was first officially described in Brazil on February 26th, 2020. The accumulation of reports of concomitant infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathogens that cause diseases endemic to tropical countries, such as dengue and chikungunya fever, has started to draw attention. Chagas disease and leprosy remain public health problems in many developing countries, such as Brazil. In this manuscript, we describe a case of concomitant leprosy, Chagas disease, and COVID-19, highlighting the cutaneous manifestations of SARS-CoV-2 infection and the clinical behavior of household contacts who previously received prophylactic Bacillus Calmette-Guérin vaccines.
PY - 2020 EP - e20200504 T2 - Revista da Sociedade Brasileira de Medicina Tropical TI - The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy. UR - https://www.scielo.br/pdf/rsbmt/v53/1678-9849-rsbmt-53-e20200504.pdf VL - 53 SN - 1678-9849 ER -